NasdaqCM - Nasdaq Real Time Price USD
MEI Pharma, Inc. (MEIP)
1.9800
+0.0700
+(3.66%)
At close: April 22 at 4:00:00 PM EDT
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Cash Flow
-36,043
-50,473
-52,484
-48,746
-31,964
Investing Cash Flow
54,816
49,140
53,690
6,892
24,708
Financing Cash Flow
-208
-11,868
-40
49,051
3,468
End Cash Position
23,739
3,705
16,906
15,740
8,543
Income Tax Paid Supplemental Data
--
--
--
--
8
Capital Expenditure
--
-7
-35
-479
-708
Issuance of Capital Stock
--
--
--
52,325
3,200
Free Cash Flow
-36,043
-50,480
-52,519
-49,225
-32,672
6/30/2021 - 12/18/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AVTE Aerovate Therapeutics, Inc.
2.7600
-0.36%
ARMP Armata Pharmaceuticals, Inc.
1.3059
+5.31%
DIABIO.ST Diagonal Bio AB (publ)
0.0145
0.00%
BT3.BE Lineage Cell Therapeutics Inc
0.3720
+10.71%
2CUREX.ST 2cureX AB (publ)
0.5900
-0.34%
HTD.MU Corcept Therapeutics Inc
56.94
+3.98%
GON.DU Geron Corp
1.1400
-0.18%
RASP Actavia Life Sciences, Inc.
0.0040
0.00%
STABL.ST Stayble Therapeutics AB (publ)
0.4725
-3.18%
0M4.DU Mersana Therapeutics Inc
0.3341
+3.63%